CRISPR

CRISPR1-eif2b5

ID
ZDB-CRISPR-210816-1
Name
CRISPR1-eif2b5
Previous Names
None
Target
Sequence
5' - GCCACCAGAACGGCCTGCAG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The PAM site was "CGG" at the 3' end.
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zc101 eif2b5
zc102 eif2b5
zc103 eif2b5
zc104 eif2b5
zc105 eif2b5
zc106 eif2b5
Expression
Gene expression in Wild Types + CRISPR1-eif2b5
No data available
Phenotype
Phenotype resulting from CRISPR1-eif2b5
No data available
Phenotype of all Fish created by or utilizing CRISPR1-eif2b5
Phenotype Fish Conditions Figures
optic tectum neuron proliferative, abnormal eif2b5zc102/zc102 standard conditions Figure 5 with image from Keefe et al., 2020
axis cell population proliferation increased occurrence, abnormal eif2b5zc102/zc102 standard conditions Figure 5 with image from Keefe et al., 2020
axis microglial cell proliferative, abnormal eif2b5zc102/zc102 standard conditions Figure 5 with image from Keefe et al., 2020
microglial cell proliferative, abnormal eif2b5zc102/zc102 standard conditions Figure 5 with image from Keefe et al., 2020
head decreased size, abnormal eif2b5zc102/zc102 standard conditions Figure 2 with image from Keefe et al., 2020
axis radial glial cell proliferative, abnormal eif2b5zc102/zc102 standard conditions Figure 5 with image from Keefe et al., 2020
spinal cord glioblast apoptotic, abnormal eif2b5zc102/zc102 standard conditions Figure 4 with image from Keefe et al., 2020
swimming decreased occurrence, abnormal eif2b5zc102/zc102 standard conditions Figure 2 with image from Keefe et al., 2020
neuron cell population proliferation decreased occurrence, abnormal eif2b5zc102/zc102 standard conditions Figure 5 with image from Keefe et al., 2020
brain apoptotic process increased occurrence, abnormal eif2b5zc102/zc102 standard conditions Figure 3 with imageFigure 4 with imageFigure 5 with image from Keefe et al., 2020
optic tectum cell population proliferation decreased occurrence, abnormal eif2b5zc102/zc102 standard conditions Figure 3 with image from Keefe et al., 2020
hindbrain glioblast apoptotic, abnormal eif2b5zc102/zc102 standard conditions Figure 4 with image from Keefe et al., 2020
whole organism decreased size, abnormal eif2b5zc102/zc102 standard conditions Figure 2 with image from Keefe et al., 2020
swim bladder absent, abnormal eif2b5zc102/zc102 standard conditions Figure 2 with image from Keefe et al., 2020
glioblast apoptotic process increased occurrence, abnormal eif2b5zc102/zc102 standard conditions Figure 4 with image from Keefe et al., 2020
radial glial cell apoptotic process increased occurrence, abnormal eif2b5zc102/zc102 standard conditions Figure 5 with image from Keefe et al., 2020
whole organism dead, abnormal eif2b5zc102/zc102 standard conditions Figure 2 with image from Keefe et al., 2020
axis cell population proliferation increased occurrence, abnormal eif2b5zc103/zc103 standard conditions Figure 5 with image from Keefe et al., 2020
cranial nerve II myelin sheath decreased thickness, abnormal eif2b5zc103/zc103 standard conditions Figure 6 with image from Keefe et al., 2020
axis radial glial cell proliferative, abnormal eif2b5zc103/zc103 standard conditions Figure 5 with image from Keefe et al., 2020
spinal cord glioblast apoptotic, abnormal eif2b5zc103/zc103 standard conditions Figure 4 with image from Keefe et al., 2020
brain apoptotic process increased occurrence, abnormal eif2b5zc103/zc103 standard conditions Figure 3 with imageFigure 4 with image from Keefe et al., 2020
hindbrain glioblast apoptotic, abnormal eif2b5zc103/zc103 standard conditions Figure 4 with image from Keefe et al., 2020
brain decreased size, abnormal eif2b5zc103/zc103 standard conditions Figure 6 with image from Keefe et al., 2020
whole organism decreased size, abnormal eif2b5zc103/zc103 standard conditions Figure 2 with image from Keefe et al., 2020
glioblast apoptotic process increased occurrence, abnormal eif2b5zc103/zc103 standard conditions Figure 4 with image from Keefe et al., 2020
cranial nerve II axon decreased diameter, abnormal eif2b5zc103/zc103 standard conditions Figure 6 with image from Keefe et al., 2020
hindbrain glioblast apoptotic, abnormal eif2b5zc102/zc102; vu19Tg standard conditions Figure 3 with image from Keefe et al., 2020
glioblast apoptotic process increased occurrence, abnormal eif2b5zc102/zc102; vu19Tg standard conditions Figure 3 with image from Keefe et al., 2020
hindbrain glioblast apoptotic, abnormal eif2b5zc103/zc103; vu19Tg standard conditions Figure 3 with image from Keefe et al., 2020
glioblast apoptotic process increased occurrence, abnormal eif2b5zc103/zc103; vu19Tg standard conditions Figure 3 with image from Keefe et al., 2020
Citations